Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

The Itpr3 gene causes a specific hair pattern in mice.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Baricitinib helps treat severe hair loss in people over 65.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Tofacitinib helped regrow hair in a woman with alopecia areata.

A patient with complete hair loss regrew all her hair using tofacitinib.

A new compound shows promise as a topical treatment for hair loss.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

The new treatment showed promise in managing eyebrow hair loss.

PandaOmics uses AI to find new disease treatment targets and biomarkers.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib might be used to treat hair loss.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

The patch effectively promotes hair growth for alopecia areata without pain.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

The TIP1 gene is crucial for normal plant cell growth in Arabidopsis.